HealthEquity (HQY) Tops Q3 EPS by 10c, Beats on Revenue; Offers Guidance

HealthEquity (NASDAQ: HQY) reported Q3 EPS of $1.01, $0.10 better than the analyst estimate of $0.91. Revenue for the quarter came in at $322.2 million versus the consensus estimate of $320.92 million.

GUIDANCE:

HealthEquity sees FY2026 EPS of $3.87-$3.95, versus the consensus of $3.89. HealthEquity sees FY2026 revenue of $1.3-1.31 billion, versus the consensus of $1.31 billion.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Occidental Petroleum releases Q2 2026 earnings considerations
• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• GuideAI Health hires firms for marketing and investor outreach